CELLSAVE LIMITED

What CELLSAVE LIMITED does

CellSave Arabia FZ-LLC (operating as CELLSAVE LIMITED) is a UAE-incorporated stem cell banking company that preserves newborn stem cells from five distinct perinatal sources — cord blood, cord tissue, placenta, amnion tissue, and cord vessels — using cryogenic liquid nitrogen dewars maintained at -196°C. Quality assessment includes Total Nucleated Cell (TNC) counts, CD34+/CD45 marker analysis, viability testing, and screening for bacterial, fungal, and infectious agents. The company operates three accredited laboratories across the GCC: Dubai (since 2005, headquarters in Dubai Healthcare City), Qatar (since 2010, Qatar Free Zone), and Abu Dhabi (since 2023, Masdar City), making it the longest-established dedicated stem cell bank in the UAE with over 350,000 families served and 750,000+ stem cell units stored. Its regulatory portfolio includes AABB accreditation for cord blood (2006) and somatic cells (2024), ISO 20387 (first biobank worldwide, 2025), FDA registration, and DHA, MOH, DHCC, and DOH licenses.

The company sells a tiered package portfolio — CryoAdvanced (AED 23,500), CryoUltimate (AED 28,500), and CryoInfinite (AED 39,500) — each including a collection kit, processing, and 30-year cryogenic storage with a $100,000 engraftment guarantee. The premium CryoInfinite package adds MSC isolation and culturing to create a Master Stem Cell Bank yielding ~1,037 treatment doses (~415 billion cells) per family for regenerative medicine applications. Revenue combines one-time enrollment and processing fees with recurring storage subscriptions (extending beyond the initial 30-year term), supported by 3- to 18-month installment plans.

Go-to-market is direct-to-consumer targeting expectant parents across the GCC, distributed through a bilingual (Arabic/English) e-commerce website, 24/7 toll-free phone lines and WhatsApp support, SEO-driven content marketing, and a channel network of hospitals, obstetricians, and midwives who perform the physical collection at birth. The company is led by CEO Sarah Al-Hajali and has been covered by Forbes, Khaleej Times, Sky News Arabia, and Health Magazine for its accreditation milestones and expansion plans.

Name

CELLSAVE LIMITED

Legal name

CellSave Arabia FZ-LLC

Website

https://cellsave.com

Company type

Private

Founded year

2005

Operating status

Operating

Short description

CellSave Arabia is a UAE-based stem cell bank that preserves newborn cord blood and perinatal tissue stem cells for families across the GCC, operating accredited laboratories in Dubai, Abu Dhabi, and Qatar serving over 350,000 families.

Ownership category

akta.pro rank

Product category

Stem Cell Banking Services

NAICS

Blood and Organ Banks (621991)

SIC

Services-Health Services (8000)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

akta.pro secondary industries

Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN), Cell Therapy Manufacturing Services (GMP, autologous/allogeneic) (HLAAAKAC), Stem Cell–Based Regenerative Therapies (HLAAAGAA)

Keywords

• Stem cell banking
• Cord blood preservation
• Cryogenic storage services
• Perinatal tissue banking
• Regenerative medicine services

Headquarters

HQ city

Bedford

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Stem Cell Banking Enrollment and Kit: One-time enrollment fee covering account setup, collection kit, and delivery. Combined with processing fee for stem cell collection and testing. CryoAdvanced package totals 23,500 AED (Enrollment 3,500 AED + Processing 11,000 AED + Storage 9,000 AED). Additional 4-chamber storage bag available for 1,000 AED.
2. Long-Term Cryogenic Storage Subscription: 30-year storage subscription included in all packages. CryoUltimate at 28,500 AED and CryoInfinite at 39,500 AED. Payment plans available: monthly installments over 3, 6, 9, or 12 months (CryoAdvanced at 750 AED/month for 12 months; CryoUltimate at 875 AED/month for 12 months; CryoInfinite at 778 AED/month for 18 months). Recurring storage fees continue after the initial period.
3. Regenerative Medicine MSC Doses (CryoInfinite): CryoInfinite package provides access to an infinite supply of cultured mesenchymal stem cells for personal and family use in regenerative medicine treatments, including anti-aging, orthopedics, hair loss, and wellness applications — representing a unique high-value upsell over base storage packages.
4. Sample Release and Retrieval: When families need to access their stored stem cells, the company facilitates worldwide sample transportation within an hour of need. This service supports medical treatments for conditions including leukemia, thalassemia, and regenerative therapies.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

CellSave provides cryogenic collection, processing, and long-term storage of newborn stem cells from umbilical cord blood, cord tissue, placenta, amnion, and cord vessels for expectant parents across the UAE and Qatar. The company offers tiered service packages (CryoAdvanced, CryoUltimate, CryoInfinite) with 30-year storage guarantees, including a proprietary Master Stem Cell Bank offering a practically unlimited supply of cultured mesenchymal stem cells for regenerative medicine applications. The end-to-end service encompasses a collection kit, hospital-side collection support, temperature-controlled courier pickup, and accredited laboratory processing across three GCC facilities.

Product overview

CellSave offers a tiered portfolio of stem cell banking services for newborn stem cells. The core offerings include CryoAdvanced (AED 23,500), CryoUltimate (AED 28,500), and CryoInfinite (AED 39,500), which progressively expand coverage from cord blood, cord tissue, and placenta storage to include amnion tissue, cord vessels, and unlimited mesenchymal stem cell doses. All packages include collection kits, processing, 30-year storage, and AABB-accredited laboratory services. The company operates facilities in Dubai, Abu Dhabi, and Qatar, serving families across the GCC region.

Differentiator

Problem solved

Functional benefit

Brands

• CryoAdvanced: Stem cell banking package preserving cord blood, cord tissue, and placenta at AED 23,500 for 30-year storage.
• CryoUltimate
• CryoInfinite

Products and services

• CryoAdvanced Stem cell banking package preserving cord blood, cord tissue, and placenta for 30 years at AED 23,500. Includes collection kit, prepaid shipping, processing, 30-year storage, free HLA testing, and a $100,000 engraftment guarantee. Targeted at expectant parents seeking core perinatal stem cell preservation.
• CryoUltimate Comprehensive stem cell banking package covering five perinatal stem cell sources — cord blood, cord tissue, placenta, amnion tissue, and cord vessels — for 30 years at AED 28,500. Offers broader coverage of stem cell sources than CryoAdvanced. Targeted at families seeking the most extensive preservation of available perinatal tissues.
• CryoInfinite Premium stem cell banking package at AED 39,500 that includes all CryoUltimate sources plus an infinite supply of ready-to-use mesenchymal stem cells (MSCs) from cord tissue for regenerative medicine applications such as anti-aging, orthopedics, hair loss, and ovarian rejuvenation. The proprietary Master Stem Cell Bank provides approximately 1,037 treatment doses (200–400 million cells each, totaling ~415 billion cells) per family.

Quantifiable outcome

• 350,000+ families have stored stem cells with CellSave
• +5 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Partner Hospitals and Healthcare ProviderscoreChannel Partner/ Reseller/ DistributorCellSave partners with hospitals, obstetricians, gynecologists, and midwives across the UAE and Qatar to collect cord blood, cord tissue, placenta, amnion, and cord vessel samples at birth. The company provides collection kits and training to healthcare providers, who serve as the primary point of stem cell collection for families.
• Bioscience Institute (CellSave Arabia Bioscience Institute)coreStrategic or Co-development PartnerCellSave Arabia Bioscience Institute, in partnership with WAM (UAE News Agency), was unveiled as part of CellSave's expanded service offerings, indicating co-development of advanced bioscience capabilities including exosome banking and regenerative medicine research.
• Khaleej Times, Sky News Arabia, Health Magazine, Forbes Middle East, Arabian BusinessminorGTM or Marketing PartnerCellSave is featured in prominent regional and international media outlets (Khaleej Times, Sky News Arabia, Health Magazine, Forbes Middle East, Arabian Business) which provide editorial coverage and media exposure for the company's services, accreditations, and expansion plans — functioning as earned media and GTM amplification partners.

Scale indicators8 records

Recent moves10 records

Expansion highlights5 records

Broad incumbents

• Cryo-Cell International: US-based, publicly traded cord blood bank (and broader women's health storage) with multi-decade operating history. Comparable in core offering (cord blood + tissue banking) but with a much wider service portfolio and US/global footprint.
• ViaCord: US cord blood and cord tissue bank, now part of Revvity/PerkinElmer. Comparable in cord blood/tissue product structure and consumer-facing positioning, with broader corporate infrastructure and US-centric reach.

Direct peers

• Cells4Life: UK perinatal tissue banking specialist offering cord blood, cord tissue, and placental storage with tiered packages. Direct competitor on product structure, length of storage, and DTC education-led go-to-market.
• StemCyte: US/global cord blood bank with both private and public banking arms and therapeutic applications. Comparable in product offering (cord blood + tissue) and in operating a multi-jurisdictional accredited biobank.
• Smart Cells International: UK-based private cord blood and stem cell bank with a similar direct-to-consumer model targeting expectant parents. Closely comparable in product structure (cord blood, cord tissue, MSC options), 20–30 year storage, and consumer marketing playbook.
• Precious Cells International: UK-based stem cell storage provider offering cord blood, cord tissue, and dental pulp banking. Closely comparable in DTC targeting of expectant parents, package structure, and European consumer-marketed model.
• Future Health Biobank: UK-accredited stem cell storage company offering cord blood, cord tissue, and dental pulp banking with multi-year storage. Closely comparable in service scope, accreditation posture, and European consumer-marketed positioning.
• Biovault Family: UK private stem cell bank offering cord blood and tissue storage with HTA-licensed processing. Directly comparable in DTC consumer model, accreditation-driven positioning, and long-term storage proposition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cellsave

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CELLSAVE LIMITED